Stock Markets Torn Between Optimism Over Vaccines And Discouragement Over Macro Data
November 23, 2020 at 07:39 AM EST
AstraZeneca announced today that its vaccine, developed together with the University of Oxford, shows 90% efficacy in one of its trials by administering "half a dose, followed by a full dose with an interval of at least one month ".